Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration
Open Access
- 28 July 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (30), 12483-12488
- https://doi.org/10.1073/pnas.0904239106
Abstract
The clinical evaluation of neural transplantation as a potential treatment for Huntington9s disease (HD) was initiated in an attempt to replace lost neurons and improve patient outcomes. Two of 3 patients with HD reported here, who underwent neural transplantation containing striatal anlagen in the striatum a decade earlier, have demonstrated marginal and transient clinical benefits. Their brains were evaluated immunohistochemically and with electron microscopy for markers of projection neurons and interneurons, inflammatory cells, abnormal huntingtin protein, and host-derived connectivity. Surviving grafts were identified bilaterally in 2 of the subjects and displayed classic striatal projection neurons and interneurons. Genetic markers of HD were not expressed within the graft. Here we report in patients with HD that (i) graft survival is attenuated long-term; (ii) grafts undergo disease-like neuronal degeneration with a preferential loss of projection neurons in comparison to interneurons; (iii) immunologically unrelated cells degenerate more rapidly than the patient9s neurons, particularly the projection neuron subtype; (iv) graft survival is attenuated in the caudate in comparison to the putamen in HD; (v) glutamatergic cortical neurons project to transplanted striatal neurons; and (vi) microglial inflammatory changes in the grafts specifically target the neuronal components of the grafts. These results, when combined, raise uncertainty about this potential therapeutic approach for the treatment of HD. However, these observations provide new opportunities to investigate the underlying mechanisms involved in HD, as well as to explore additional therapeutic paradigms.Keywords
This publication has 62 references indexed in Scilit:
- Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s diseaseNeurobiology of Disease, 2008
- Neural transplantation in Huntington disease: Long-term grafts in two patientsNeurology, 2007
- Neuronal death: where does the end begin?Trends in Neurosciences, 2007
- Safety of Intrastriatal Neurotransplantation for Huntington's Disease PatientsExperimental Neurology, 1998
- Ontogeny of Human Striatal DARPP-32 Neurons in Fetuses and Following Xenografting to the Adult Rat BrainExperimental Neurology, 1996
- Development of the human striatum: Implications for fetal striatal transplantation in the treatment of Huntington's diseaseCell Transplantation, 1995
- Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibresNature Medicine, 1995
- The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidenceBrain Research, 1994
- Anatomy and connectivity of intrastriatal striatal transplantsProgress in Neurobiology, 1992
- Intracerebral grafting of dissociated CNS tissue suspensions: a new approach for neuronal transplantation to deep brain sitesBrain Research, 1981